APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antacids

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Antacids Market Analysis and Forecast 2026-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchAntacids Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Antacids Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Antacids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antacids Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Antacids Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Antacids market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Antacids is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Antacids is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Antacids is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Antacids is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Antacids include Xiuzheng Pharma, Takeda Pharmaceutical, Sanofi, Johnson & Johnson, Novartis, Reckitt Benckiser, CONBA, Pfizer and CR SANJIU, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Antacids, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antacids, also provides the sales of main regions and countries. Of the upcoming market potential for Antacids, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antacids sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antacids market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Antacids sales, projected growth trends, production technology, application and end-user industry.

Antacids Segment by Company

Xiuzheng Pharma

Takeda Pharmaceutical

Sanofi

Johnson & Johnson

Novartis

Reckitt Benckiser

CONBA

Pfizer

CR SANJIU

GlaxoSmithKline

Bausch Health

Procter & Gamble

Bayer

AstraZeneca

Antacids Segment by Type

Non-Systemic Antacids

Systemic Antacids

Antacids Segment by Application

Rx Drug

OTC Drug

Antacids Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antacids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antacids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antacids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Antacids in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Antacids manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antacids sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antacids Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Non-Systemic Antacids Major Manufacturers Table 3. Systemic Antacids Major Manufacturers Table 4. Global Antacids Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Rx Drug Major Manufacturers Table 6. OTC Drug Major Manufacturers Table 7. Antacids Industry Trends Table 8. Antacids Industry Drivers Table 9. Antacids Industry Opportunities and Challenges Table 10. Antacids Industry Restraints Table 11. Global Antacids Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Antacids Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Antacids Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Antacids Revenue Market Share by Region (2021-2026) Table 15. Global Antacids Revenue Market Share by Region (2027-2032) Table 16. Global Antacids Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Antacids Sales by Region (2021-2026) & (k units) Table 18. Global Antacids Sales by Region (2027-2032) & (k units) Table 19. Global Antacids Sales Market Share by Region (2021-2026) Table 20. Global Antacids Sales Market Share by Region (2027-2032) Table 21. Global Antacids Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Antacids Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Antacids Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Antacids Sales Market Share by Manufacturers (2021-2026) Table 25. Global Antacids Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Antacids Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Antacids Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Antacids Manufacturers, Product Type & Application Table 29. Global Antacids Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Antacids by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Antacids Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Antacids Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Antacids Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Antacids Revenue Market Share by Type (2021-2026) Table 36. Global Antacids Revenue Market Share by Type (2027-2032) Table 37. Global Antacids Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Antacids Sales by Type (2021-2026) & (k units) Table 39. Global Antacids Sales by Type (2027-2032) & (k units) Table 40. Global Antacids Sales Market Share by Type (2021-2026) Table 41. Global Antacids Sales Market Share by Type (2027-2032) Table 42. Global Antacids Price by Type (2021-2026) & (US$/unit) Table 43. Global Antacids Price by Type (2027-2032) & (US$/unit) Table 44. Global Antacids Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Antacids Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Antacids Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Antacids Revenue Market Share by Application (2021-2026) Table 48. Global Antacids Revenue Market Share by Application (2027-2032) Table 49. Global Antacids Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Antacids Sales by Application (2021-2026) & (k units) Table 51. Global Antacids Sales by Application (2027-2032) & (k units) Table 52. Global Antacids Sales Market Share by Application (2021-2026) Table 53. Global Antacids Sales Market Share by Application (2027-2032) Table 54. Global Antacids Price by Application (2021-2026) & (US$/unit) Table 55. Global Antacids Price by Application (2027-2032) & (US$/unit) Table 56. Xiuzheng Pharma Company Information Table 57. Xiuzheng Pharma Business Overview Table 58. Xiuzheng Pharma Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Xiuzheng Pharma Antacids Product Portfolio Table 60. Xiuzheng Pharma Recent Development Table 61. Takeda Pharmaceutical Company Information Table 62. Takeda Pharmaceutical Business Overview Table 63. Takeda Pharmaceutical Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Takeda Pharmaceutical Antacids Product Portfolio Table 65. Takeda Pharmaceutical Recent Development Table 66. Sanofi Company Information Table 67. Sanofi Business Overview Table 68. Sanofi Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Sanofi Antacids Product Portfolio Table 70. Sanofi Recent Development Table 71. Johnson & Johnson Company Information Table 72. Johnson & Johnson Business Overview Table 73. Johnson & Johnson Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Johnson & Johnson Antacids Product Portfolio Table 75. Johnson & Johnson Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Novartis Antacids Product Portfolio Table 80. Novartis Recent Development Table 81. Reckitt Benckiser Company Information Table 82. Reckitt Benckiser Business Overview Table 83. Reckitt Benckiser Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Reckitt Benckiser Antacids Product Portfolio Table 85. Reckitt Benckiser Recent Development Table 86. CONBA Company Information Table 87. CONBA Business Overview Table 88. CONBA Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. CONBA Antacids Product Portfolio Table 90. CONBA Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Pfizer Antacids Product Portfolio Table 95. Pfizer Recent Development Table 96. CR SANJIU Company Information Table 97. CR SANJIU Business Overview Table 98. CR SANJIU Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. CR SANJIU Antacids Product Portfolio Table 100. CR SANJIU Recent Development Table 101. GlaxoSmithKline Company Information Table 102. GlaxoSmithKline Business Overview Table 103. GlaxoSmithKline Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. GlaxoSmithKline Antacids Product Portfolio Table 105. GlaxoSmithKline Recent Development Table 106. Bausch Health Company Information Table 107. Bausch Health Business Overview Table 108. Bausch Health Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Bausch Health Antacids Product Portfolio Table 110. Bausch Health Recent Development Table 111. Procter & Gamble Company Information Table 112. Procter & Gamble Business Overview Table 113. Procter & Gamble Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Procter & Gamble Antacids Product Portfolio Table 115. Procter & Gamble Recent Development Table 116. Bayer Company Information Table 117. Bayer Business Overview Table 118. Bayer Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Bayer Antacids Product Portfolio Table 120. Bayer Recent Development Table 121. AstraZeneca Company Information Table 122. AstraZeneca Business Overview Table 123. AstraZeneca Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. AstraZeneca Antacids Product Portfolio Table 125. AstraZeneca Recent Development Table 126. North America Antacids Revenue by Type (2021-2026) & (US$ Million) Table 127. North America Antacids Revenue by Type (2027-2032) & (US$ Million) Table 128. North America Antacids Sales by Type (2021-2026) & (k units) Table 129. North America Antacids Sales by Type (2027-2032) & (k units) Table 130. North America Antacids Sales Price by Type (2021-2026) & (US$/unit) Table 131. North America Antacids Sales Price by Type (2027-2032) & (US$/unit) Table 132. North America Antacids Revenue by Application (2021-2026) & (US$ Million) Table 133. North America Antacids Revenue by Application (2027-2032) & (US$ Million) Table 134. North America Antacids Sales by Application (2021-2026) & (k units) Table 135. North America Antacids Sales by Application (2027-2032) & (k units) Table 136. North America Antacids Sales Price by Application (2021-2026) & (US$/unit) Table 137. North America Antacids Sales Price by Application (2027-2032) & (US$/unit) Table 138. North America Antacids Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. North America Antacids Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. North America Antacids Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. North America Antacids Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 142. North America Antacids Sales by Country (2021-2026) & (k units) Table 143. North America Antacids Sales by Country (2027-2032) & (k units) Table 144. North America Antacids Sales Price by Country (2021-2026) & (US$/unit) Table 145. North America Antacids Sales Price by Country (2027-2032) & (US$/unit) Table 146. United States Antacids Revenue (2021-2032) & (US$ Million) Table 147. Canada Antacids Revenue (2021-2032) & (US$ Million) Table 148. Mexico Antacids Revenue (2021-2032) & (US$ Million) Table 149. Europe Antacids Revenue by Type (2021-2026) & (US$ Million) Table 150. Europe Antacids Revenue by Type (2027-2032) & (US$ Million) Table 151. Europe Antacids Sales by Type (2021-2026) & (k units) Table 152. Europe Antacids Sales by Type (2027-2032) & (k units) Table 153. Europe Antacids Sales Price by Type (2021-2026) & (US$/unit) Table 154. Europe Antacids Sales Price by Type (2027-2032) & (US$/unit) Table 155. Europe Antacids Revenue by Application (2021-2026) & (US$ Million) Table 156. Europe Antacids Revenue by Application (2027-2032) & (US$ Million) Table 157. Europe Antacids Sales by Application (2021-2026) & (k units) Table 158. Europe Antacids Sales by Application (2027-2032) & (k units) Table 159. Europe Antacids Sales Price by Application (2021-2026) & (US$/unit) Table 160. Europe Antacids Sales Price by Application (2027-2032) & (US$/unit) Table 161. Europe Antacids Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Europe Antacids Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. Europe Antacids Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. Europe Antacids Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 165. Europe Antacids Sales by Country (2021-2026) & (k units) Table 166. Europe Antacids Sales by Country (2027-2032) & (k units) Table 167. Europe Antacids Sales Price by Country (2021-2026) & (US$/unit) Table 168. Europe Antacids Sales Price by Country (2027-2032) & (US$/unit) Table 169. Germany Antacids Revenue (2021-2032) & (US$ Million) Table 170. France Antacids Revenue (2021-2032) & (US$ Million) Table 171. U.K. Antacids Revenue (2021-2032) & (US$ Million) Table 172. Italy Antacids Revenue (2021-2032) & (US$ Million) Table 173. Russia Antacids Revenue (2021-2032) & (US$ Million) Table 174. Spain Antacids Revenue (2021-2032) & (US$ Million) Table 175. Netherlands Antacids Revenue (2021-2032) & (US$ Million) Table 176. Switzerland Antacids Revenue (2021-2032) & (US$ Million) Table 177. Sweden Antacids Revenue (2021-2032) & (US$ Million) Table 178. Poland Antacids Revenue (2021-2032) & (US$ Million) Table 179. China Antacids Revenue by Type (2021-2026) & (US$ Million) Table 180. China Antacids Revenue by Type (2027-2032) & (US$ Million) Table 181. China Antacids Sales by Type (2021-2026) & (k units) Table 182. China Antacids Sales by Type (2027-2032) & (k units) Table 183. China Antacids Sales Price by Type (2021-2026) & (US$/unit) Table 184. China Antacids Sales Price by Type (2027-2032) & (US$/unit) Table 185. China Antacids Revenue by Application (2021-2026) & (US$ Million) Table 186. China Antacids Revenue by Application (2027-2032) & (US$ Million) Table 187. China Antacids Sales by Application (2021-2026) & (k units) Table 188. China Antacids Sales by Application (2027-2032) & (k units) Table 189. China Antacids Sales Price by Application (2021-2026) & (US$/unit) Table 190. China Antacids Sales Price by Application (2027-2032) & (US$/unit) Table 191. Asia Antacids Revenue by Type (2021-2026) & (US$ Million) Table 192. Asia Antacids Revenue by Type (2027-2032) & (US$ Million) Table 193. Asia Antacids Sales by Type (2021-2026) & (k units) Table 194. Asia Antacids Sales by Type (2027-2032) & (k units) Table 195. Asia Antacids Sales Price by Type (2021-2026) & (US$/unit) Table 196. Asia Antacids Sales Price by Type (2027-2032) & (US$/unit) Table 197. Asia Antacids Revenue by Application (2021-2026) & (US$ Million) Table 198. Asia Antacids Revenue by Application (2027-2032) & (US$ Million) Table 199. Asia Antacids Sales by Application (2021-2026) & (k units) Table 200. Asia Antacids Sales by Application (2027-2032) & (k units) Table 201. Asia Antacids Sales Price by Application (2021-2026) & (US$/unit) Table 202. Asia Antacids Sales Price by Application (2027-2032) & (US$/unit) Table 203. Asia Antacids Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 204. Asia Antacids Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 205. Asia Antacids Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 206. Asia Antacids Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 207. Asia Antacids Sales by Country (2021-2026) & (k units) Table 208. Asia Antacids Sales by Country (2027-2032) & (k units) Table 209. Asia Antacids Sales Price by Country (2021-2026) & (US$/unit) Table 210. Asia Antacids Sales Price by Country (2027-2032) & (US$/unit) Table 211. Japan Antacids Revenue (2021-2032) & (US$ Million) Table 212. South Korea Antacids Revenue (2021-2032) & (US$ Million) Table 213. India Antacids Revenue (2021-2032) & (US$ Million) Table 214. Australia Antacids Revenue (2021-2032) & (US$ Million) Table 215. Taiwan Antacids Revenue (2021-2032) & (US$ Million) Table 216. Southeast Asia Antacids Revenue (2021-2032) & (US$ Million) Table 217. SAMEA Antacids Revenue by Type (2021-2026) & (US$ Million) Table 218. SAMEA Antacids Revenue by Type (2027-2032) & (US$ Million) Table 219. SAMEA Antacids Sales by Type (2021-2026) & (k units) Table 220. SAMEA Antacids Sales by Type (2027-2032) & (k units) Table 221. SAMEA Antacids Sales Price by Type (2021-2026) & (US$/unit) Table 222. SAMEA Antacids Sales Price by Type (2027-2032) & (US$/unit) Table 223. SAMEA Antacids Revenue by Application (2021-2026) & (US$ Million) Table 224. SAMEA Antacids Revenue by Application (2027-2032) & (US$ Million) Table 225. SAMEA Antacids Sales by Application (2021-2026) & (k units) Table 226. SAMEA Antacids Sales by Application (2027-2032) & (k units) Table 227. SAMEA Antacids Sales Price by Application (2021-2026) & (US$/unit) Table 228. SAMEA Antacids Sales Price by Application (2027-2032) & (US$/unit) Table 229. SAMEA Antacids Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 230. SAMEA Antacids Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 231. SAMEA Antacids Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 232. SAMEA Antacids Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 233. SAMEA Antacids Sales by Country (2021-2026) & (k units) Table 234. SAMEA Antacids Sales by Country (2027-2032) & (k units) Table 235. SAMEA Antacids Sales Price by Country (2021-2026) & (US$/unit) Table 236. SAMEA Antacids Sales Price by Country (2027-2032) & (US$/unit) Table 237. Brazil Antacids Revenue (2021-2032) & (US$ Million) Table 238. Argentina Antacids Revenue (2021-2032) & (US$ Million) Table 239. Chile Antacids Revenue (2021-2032) & (US$ Million) Table 240. Colombia Antacids Revenue (2021-2032) & (US$ Million) Table 241. Peru Antacids Revenue (2021-2032) & (US$ Million) Table 242. Saudi Arabia Antacids Revenue (2021-2032) & (US$ Million) Table 243. Israel Antacids Revenue (2021-2032) & (US$ Million) Table 244. UAE Antacids Revenue (2021-2032) & (US$ Million) Table 245. Turkey Antacids Revenue (2021-2032) & (US$ Million) Table 246. Iran Antacids Revenue (2021-2032) & (US$ Million) Table 247. Egypt Antacids Revenue (2021-2032) & (US$ Million) Table 248. Key Raw Materials Table 249. Raw Materials Key Suppliers Table 250. Antacids Distributors List Table 251. Antacids Customers List Table 252. Research Programs/Design for This Report Table 253. Authors List of This Report Table 254. Secondary Sources Table 255. Primary Sources List of Figures Figure 1. Antacids Image Figure 2. Global Antacids Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antacids Market Size Share 2021 VS 2025 VS 2032 Figure 4. Non-Systemic Antacids Image Figure 5. Systemic Antacids Image Figure 6. Global Antacids Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Antacids Market Size Share 2021 VS 2025 VS 2032 Figure 8. Rx Drug Image Figure 9. OTC Drug Image Figure 10. Global Antacids Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Antacids Revenue (2021-2032) & (US$ Million) Figure 12. Global Antacids Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Antacids Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Antacids Revenue Market Share by Region (2021-2032) Figure 15. Global Antacids Sales (2021-2032) & (k units) Figure 16. Global Antacids Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Antacids Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Antacids Sales YoY (2021-2032) & (k units) Figure 19. Europe Antacids Sales YoY (2021-2032) & (k units) Figure 20. China Antacids Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Antacids Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Antacids Sales YoY (2021-2032) & (k units) Figure 23. Global Antacids Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Antacids Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Antacids Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Antacids Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Antacids Revenue Market Share by Type (2021-2032) Figure 29. Global Antacids Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Antacids Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Antacids Sales Market Share by Type (2021-2032) Figure 32. Global Antacids Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Antacids Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Antacids Revenue Market Share by Application (2021-2032) Figure 35. Global Antacids Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Antacids Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Antacids Sales Market Share by Application (2021-2032) Figure 38. North America Antacids Revenue Share by Type (2021-2032) Figure 39. North America Antacids Sales Share by Type (2021-2032) Figure 40. North America Antacids Revenue Share by Application (2021-2032) Figure 41. North America Antacids Sales Share by Application (2021-2032) Figure 42. North America Antacids Revenue Share by Country (2021-2032) Figure 43. North America Antacids Sales Share by Country (2021-2032) Figure 44. Europe Antacids Revenue Share by Type (2021-2032) Figure 45. Europe Antacids Sales Share by Type (2021-2032) Figure 46. Europe Antacids Revenue Share by Application (2021-2032) Figure 47. Europe Antacids Sales Share by Application (2021-2032) Figure 48. Europe Antacids Revenue Share by Country (2021-2032) Figure 49. Europe Antacids Sales Share by Country (2021-2032) Figure 50. China Antacids Revenue Share by Type (2021-2032) Figure 51. China Antacids Sales Share by Type (2021-2032) Figure 52. China Antacids Revenue Share by Application (2021-2032) Figure 53. China Antacids Sales Share by Application (2021-2032) Figure 54. Asia Antacids Revenue Share by Type (2021-2032) Figure 55. Asia Antacids Sales Share by Type (2021-2032) Figure 56. Asia Antacids Revenue Share by Application (2021-2032) Figure 57. Asia Antacids Sales Share by Application (2021-2032) Figure 58. Asia Antacids Revenue Share by Country (2021-2032) Figure 59. Asia Antacids Sales Share by Country (2021-2032) Figure 60. SAMEA Antacids Revenue Share by Type (2021-2032) Figure 61. SAMEA Antacids Sales Share by Type (2021-2032) Figure 62. SAMEA Antacids Revenue Share by Application (2021-2032) Figure 63. SAMEA Antacids Sales Share by Application (2021-2032) Figure 64. SAMEA Antacids Revenue Share by Country (2021-2032) Figure 65. SAMEA Antacids Sales Share by Country (2021-2032) Figure 66. Antacids Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Antacids Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Non-Systemic Antacids
  • Systemic Antacids
Applications
  • Rx Drug
  • OTC Drug
Companies covered
  • Xiuzheng Pharma
  • Takeda Pharmaceutical
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Reckitt Benckiser
  • CONBA
  • Pfizer
  • CR SANJIU
  • GlaxoSmithKline
  • Bausch Health
  • Procter & Gamble
  • Bayer
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antacids Market by Type
  3. 1.2.1 Global Antacids Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Non-Systemic Antacids
  5. 1.2.3 Systemic Antacids
  6. 1.3 Antacids Market by Application
  7. 1.3.1 Global Antacids Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Rx Drug
  9. 1.3.3 OTC Drug
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Antacids Market Dynamics
  1. 2.1 Antacids Industry Trends
  2. 2.2 Antacids Industry Drivers
  3. 2.3 Antacids Industry Opportunities and Challenges
  4. 2.4 Antacids Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Antacids Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Antacids Revenue by Region
  3. 3.2.1 Global Antacids Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antacids Revenue by Region (2021-2026)
  5. 3.2.3 Global Antacids Revenue by Region (2027-2032)
  6. 3.2.4 Global Antacids Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Antacids Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Antacids Sales by Region
  9. 3.4.1 Global Antacids Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Antacids Sales by Region (2021-2026)
  11. 3.4.3 Global Antacids Sales by Region (2027-2032)
  12. 3.4.4 Global Antacids Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Antacids Revenue by Manufacturers
  2. 4.1.1 Global Antacids Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Antacids Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Antacids Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antacids Sales by Manufacturers
  6. 4.2.1 Global Antacids Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Antacids Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Antacids Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Antacids Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Antacids Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Antacids Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Antacids Manufacturers, Product Type & Application
  13. 4.7 Global Antacids Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Antacids Market CR5 and HHI
  16. 4.8.2 2025 Antacids Tier 1, Tier 2, and Tier 3
5 Antacids Market by Type
  1. 5.1 Global Antacids Revenue by Type
  2. 5.1.1 Global Antacids Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Antacids Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Antacids Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Antacids Sales by Type
  6. 5.2.1 Global Antacids Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antacids Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Antacids Sales Market Share by Type (2021-2032)
  9. 5.3 Global Antacids Price by Type
6 Antacids Market by Application
  1. 6.1 Global Antacids Revenue by Application
  2. 6.1.1 Global Antacids Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Antacids Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Antacids Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Antacids Sales by Application
  6. 6.2.1 Global Antacids Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Antacids Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Antacids Sales Market Share by Application (2021-2032)
  9. 6.3 Global Antacids Price by Application
7 Company Profiles
  1. 7.1 Xiuzheng Pharma
  2. 7.1.1 Xiuzheng Pharma Company Information
  3. 7.1.2 Xiuzheng Pharma Business Overview
  4. 7.1.3 Xiuzheng Pharma Antacids Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Xiuzheng Pharma Antacids Product Portfolio
  6. 7.1.5 Xiuzheng Pharma Recent Developments
  7. 7.2 Takeda Pharmaceutical
  8. 7.2.1 Takeda Pharmaceutical Company Information
  9. 7.2.2 Takeda Pharmaceutical Business Overview
  10. 7.2.3 Takeda Pharmaceutical Antacids Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Takeda Pharmaceutical Antacids Product Portfolio
  12. 7.2.5 Takeda Pharmaceutical Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Antacids Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Antacids Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Johnson & Johnson
  20. 7.4.1 Johnson & Johnson Company Information
  21. 7.4.2 Johnson & Johnson Business Overview
  22. 7.4.3 Johnson & Johnson Antacids Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Johnson & Johnson Antacids Product Portfolio
  24. 7.4.5 Johnson & Johnson Recent Developments
  25. 7.5 Novartis
  26. 7.5.1 Novartis Company Information
  27. 7.5.2 Novartis Business Overview
  28. 7.5.3 Novartis Antacids Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Novartis Antacids Product Portfolio
  30. 7.5.5 Novartis Recent Developments
  31. 7.6 Reckitt Benckiser
  32. 7.6.1 Reckitt Benckiser Company Information
  33. 7.6.2 Reckitt Benckiser Business Overview
  34. 7.6.3 Reckitt Benckiser Antacids Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Reckitt Benckiser Antacids Product Portfolio
  36. 7.6.5 Reckitt Benckiser Recent Developments
  37. 7.7 CONBA
  38. 7.7.1 CONBA Company Information
  39. 7.7.2 CONBA Business Overview
  40. 7.7.3 CONBA Antacids Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 CONBA Antacids Product Portfolio
  42. 7.7.5 CONBA Recent Developments
  43. 7.8 Pfizer
  44. 7.8.1 Pfizer Company Information
  45. 7.8.2 Pfizer Business Overview
  46. 7.8.3 Pfizer Antacids Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Pfizer Antacids Product Portfolio
  48. 7.8.5 Pfizer Recent Developments
  49. 7.9 CR SANJIU
  50. 7.9.1 CR SANJIU Company Information
  51. 7.9.2 CR SANJIU Business Overview
  52. 7.9.3 CR SANJIU Antacids Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 CR SANJIU Antacids Product Portfolio
  54. 7.9.5 CR SANJIU Recent Developments
  55. 7.10 GlaxoSmithKline
  56. 7.10.1 GlaxoSmithKline Company Information
  57. 7.10.2 GlaxoSmithKline Business Overview
  58. 7.10.3 GlaxoSmithKline Antacids Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 GlaxoSmithKline Antacids Product Portfolio
  60. 7.10.5 GlaxoSmithKline Recent Developments
  61. 7.11 Bausch Health
  62. 7.11.1 Bausch Health Company Information
  63. 7.11.2 Bausch Health Business Overview
  64. 7.11.3 Bausch Health Antacids Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Bausch Health Antacids Product Portfolio
  66. 7.11.5 Bausch Health Recent Developments
  67. 7.12 Procter & Gamble
  68. 7.12.1 Procter & Gamble Company Information
  69. 7.12.2 Procter & Gamble Business Overview
  70. 7.12.3 Procter & Gamble Antacids Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Procter & Gamble Antacids Product Portfolio
  72. 7.12.5 Procter & Gamble Recent Developments
  73. 7.13 Bayer
  74. 7.13.1 Bayer Company Information
  75. 7.13.2 Bayer Business Overview
  76. 7.13.3 Bayer Antacids Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Bayer Antacids Product Portfolio
  78. 7.13.5 Bayer Recent Developments
  79. 7.14 AstraZeneca
  80. 7.14.1 AstraZeneca Company Information
  81. 7.14.2 AstraZeneca Business Overview
  82. 7.14.3 AstraZeneca Antacids Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 AstraZeneca Antacids Product Portfolio
  84. 7.14.5 AstraZeneca Recent Developments
8 North America
  1. 8.1 North America Antacids Market Size by Type
  2. 8.1.1 North America Antacids Revenue by Type (2021-2032)
  3. 8.1.2 North America Antacids Sales by Type (2021-2032)
  4. 8.1.3 North America Antacids Price by Type (2021-2032)
  5. 8.2 North America Antacids Market Size by Application
  6. 8.2.1 North America Antacids Revenue by Application (2021-2032)
  7. 8.2.2 North America Antacids Sales by Application (2021-2032)
  8. 8.2.3 North America Antacids Price by Application (2021-2032)
  9. 8.3 North America Antacids Market Size by Country
  10. 8.3.1 North America Antacids Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Antacids Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Antacids Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Antacids Market Size by Type
  2. 9.1.1 Europe Antacids Revenue by Type (2021-2032)
  3. 9.1.2 Europe Antacids Sales by Type (2021-2032)
  4. 9.1.3 Europe Antacids Price by Type (2021-2032)
  5. 9.2 Europe Antacids Market Size by Application
  6. 9.2.1 Europe Antacids Revenue by Application (2021-2032)
  7. 9.2.2 Europe Antacids Sales by Application (2021-2032)
  8. 9.2.3 Europe Antacids Price by Application (2021-2032)
  9. 9.3 Europe Antacids Market Size by Country
  10. 9.3.1 Europe Antacids Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Antacids Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Antacids Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Antacids Market Size by Type
  2. 10.1.1 China Antacids Revenue by Type (2021-2032)
  3. 10.1.2 China Antacids Sales by Type (2021-2032)
  4. 10.1.3 China Antacids Price by Type (2021-2032)
  5. 10.2 China Antacids Market Size by Application
  6. 10.2.1 China Antacids Revenue by Application (2021-2032)
  7. 10.2.2 China Antacids Sales by Application (2021-2032)
  8. 10.2.3 China Antacids Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antacids Market Size by Type
  2. 11.1.1 Asia Antacids Revenue by Type (2021-2032)
  3. 11.1.2 Asia Antacids Sales by Type (2021-2032)
  4. 11.1.3 Asia Antacids Price by Type (2021-2032)
  5. 11.2 Asia Antacids Market Size by Application
  6. 11.2.1 Asia Antacids Revenue by Application (2021-2032)
  7. 11.2.2 Asia Antacids Sales by Application (2021-2032)
  8. 11.2.3 Asia Antacids Price by Application (2021-2032)
  9. 11.3 Asia Antacids Market Size by Country
  10. 11.3.1 Asia Antacids Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Antacids Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Antacids Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antacids Market Size by Type
  2. 12.1.1 SAMEA Antacids Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Antacids Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Antacids Price by Type (2021-2032)
  5. 12.2 SAMEA Antacids Market Size by Application
  6. 12.2.1 SAMEA Antacids Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Antacids Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Antacids Price by Application (2021-2032)
  9. 12.3 SAMEA Antacids Market Size by Country
  10. 12.3.1 SAMEA Antacids Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Antacids Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Antacids Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Antacids Value Chain Analysis
  2. 13.1.1 Antacids Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Antacids Production Mode & Process
  6. 13.2 Antacids Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Antacids Distributors
  9. 13.2.3 Antacids Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst